CTOR vs QCOM · $105.2M cap vs P/E 16, rev $44.28B
Citius Oncology, Inc. (CTOR) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
CTOR does not have a complete income-statement cache yet.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
CTOR currently screens at market cap $105.2M. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the CTOR and QCOM stock pages for the full models.
Not investment advice.